Welcome to our dedicated page for 908 Devices news (Ticker: MASS), a resource for investors and traders seeking the latest updates and insights on 908 Devices stock.
908 Devices Inc. develops purpose-built handheld chemical analysis devices for point-of-need use in health, safety and defense technology applications. Its news centers on Mass Spec and FTIR product activity, installed-device growth, recurring revenue, and applications such as narcotics identification, toxic exposure screening and security-threat analysis.
Company updates also cover acquisitions and portfolio expansion, including the completed purchase of NIRLAB AG and its AI-powered, cloud-connected near-infrared spectroscopy platform for narcotics screening. Other recurring items include quarterly financial results, revenue outlooks, executive and strategy appointments, funded partnership revenue, and investor conference participation.
908 Devices (NASDAQ:MASS), a pioneer in handheld chemical analysis devices, has appointed Dr. Brandi Vann to its Board of Directors. Dr. Vann brings over 15 years of experience from the U.S. Department of Defense, where she served as Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense.
The appointment comes as part of the company's strategic refocus on public health, safety, and defense technology. Simultaneously, Jeff George has stepped down from the Board. Dr. Vann's extensive experience includes leadership roles at the Defense Threat Reduction Agency and oversight of critical defense programs.
908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on Wednesday, August 13 at 1:00 PM Eastern Time. Investors can access both the live and archived versions of the presentation through the investor relations section of 908 Devices' website.
908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before market open.
Management will host a conference call and webcast at 8:30 AM ET to discuss the results. Investors can access the live webcast through the company's website at www.908devices.com, with a replay available within 24 hours after the event.
908 Devices (NASDAQ:MASS) has launched VipIR, a groundbreaking 3-in-1 handheld chemical analyzer designed for field-based identification of unknown bulk substances. The device features Smart Spectral Processing (SSP), a proprietary algorithm that integrates both Raman and FTIR spectroscopy technologies into a single workflow.
VipIR includes an extensive library of over 39,000 chemical spectra and is equipped with built-in Wi-Fi and cellular connectivity. The device is specifically designed for customs, border personnel, and hazardous response teams to identify narcotics, explosives, and toxic chemicals efficiently in the field.
908 Devices (NASDAQ:MASS) partnered with Asylon Robotics to deploy gas-detecting security robots at the 2025 Indianapolis 500, the world's largest single-day sporting event with over 300,000 attendees. The collaboration featured Asylon's DroneDog-2 units equipped with 908 Devices' InterceptIR sensor for real-time air monitoring and surveillance.
The autonomous robots, built on Boston Dynamics' Spot® platform, successfully navigated GPS-denied tunnels beneath the track, maintaining operations through secure mesh communications and Starlink backup. The integration with Asylon's DroneIQ software provided emergency personnel with continuous access to live video, threat alerts, and gas detection readings.
908 Devices (NASDAQ: MASS) announced that the Romanian Customs Authority has successfully deployed 27 MX908 devices across its border operations for enhanced security measures. The handheld mass spectrometers, delivered earlier this year, enable real-time identification of trace chemicals, particularly drugs and explosives. The devices can detect trace levels of substances on vehicles, containers, and packages within seconds, allowing customs officials to make quick, informed decisions during inspections.
The order was secured through 908 Devices' channel partner, MATE-FIN, via an EU Customs Control Equipment Instrument program. The deployment and training were completed in early 2025, strengthening Romania's border security capabilities and its contribution to European Community safety.
908 Devices has secured significant contracts to supply advanced chemical detection devices to the European Union's rescEU disaster preparedness initiative. The company has delivered 108 devices to EU member states over the past six months.
Key deployments include:
- Czech Fire Brigade: 6 MX908 mass spectrometry devices for Q2 2025, adding to their existing 12 devices (XplorIR and ThreatID)
- Finland: 90 ProtectIR handheld FTIR analyzers, delivered across Q4 2024 and Q1 2025
These devices enhance disaster response capabilities by enabling rapid identification of chemical, biological, radiation, and nuclear (CBRN) threats. The MX908 can detect hazardous substances in multiple forms, while ProtectIR can identify over 23,000 chemical substances.
908 Devices (Nasdaq: MASS) has received a $2 million order from the Texas Department of Public Safety for its MX908 handheld mass spectrometry device. This follows an initial order from last year and is funded through the Community Oriented Policing Services (COPS) grant.
The MX908 devices, shipped in April, will be deployed throughout Texas at critical interdiction locations. The technology enables first responders to detect and identify trace amounts of hazardous substances, including synthetic opioids like fentanyl and nitazenes, and counterfeit pills.
The investment comes amid rising fentanyl-related deaths in Texas, which have increased by 158% from 2020 to 2023. The devices will support agencies including the Criminal Investigations Division and Narcotics Enforcement in modernizing frontline detection capabilities to combat the opioid crisis.